1. Wadhwa R, GuptaN, Dixit J, Malhotra P, Lakshmi P, Prinja S. Cost-Effectiveness Analysis ofDenosumab in the Prevention of Skeletal-Related Events Among Patients WithBreast Cancer With Bone Metastasis in India. JCO Glob Oncol. 2024Mar;10:e2300396. doi: 10.1200/GO.23.00396
2. Dixit J,Malhotra P, Mehra N, Mathew A, Kumar L, Singh A, Gupta N, Krishnamurthy MN, RoyPS, Kataki AC, Gupta S, Prinja S. Cost-Effectiveness of Novel AgentRegimens for Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients inIndia. Appl Health Econ Health Policy. 2024 Mar 7. doi:10.1007/s40258-024-00877-1.
3. Gupta D, GuptaN, Singh N, Prinja S. EconomicEvaluation of Targeted Therapies for Anaplastic Lymphoma Kinase- and ROS1Fusion-Positive Non-Small Cell Lung Cancer in India. JCO Glob Oncol.2024 Feb;10:e2300260. doi: 10.1200/GO.23.00260.
4. Gheorghe A,Mehndiratta A, Baker P, Culyer A, Prinja S, Kar SS, Guzman J. Health technology assessment inIndia in the next decade: reflections on a vision for its path to maturity andimpact. BMJ Evid Based Med. 2024 Jan 30:bmjebm-2023-112491.doi:10.1136/bmjebm-2023-112491.
5. Gupta N, Gupta D, Vaska KG, Prinja S. Cost-Effectiveness Analysis ofSystemic Therapy for Intensification of Treatment in MetastaticHormone-Sensitive Prostate Cancer in India. Appl Health Econ Health Policy. 2024 Jan 10. doi:10.1007/s40258-023-00866-w. Online ahead of print
6. Jyani G, Prinja S, Goyal A, Garg B, Kaur M,Grover S. Do people with differentsociodemographic backgrounds value their health differently? Evaluating therole of positional objectivity. Front PublicHealth. 2023 Dec 13;11:1234320. doi: 10.3389/fpubh.2023.1234320. eCollection2023.
7. Sharma M, Dhillon MS, Singh A, Prinja S, BahugunaP, Singh M, Adhya B, Negi S, Verma N. Protocol for a quasi-experimentalstudy to ascertain the effectiveness of using eKnee School approach to impartself-care education to patients suffering from knee osteoarthritis duringCOVID-19 pandemic. J Educ HealthPromot. 2023 Sep 29;12:301. doi: 10.4103/jehp.jehp_1758_22. eCollection 2023.
8. Prinja S, Chugh Y, Garg B, Guinness L. National hospital costing systemsmatter for universal healthcare: the India PM-JAY experience. BMJ Glob Health. 2023 Nov;8(11):e012987. doi:10.1136/bmjgh-2023-012987.
9. Prinja S, Bahuguna P, Singh MP, Guinness L, Goyal A, Aggarwal V. Refining the provider payment systemof India's government-funded health insurance programme: an econometricanalysis. BMJ Open. 2023Oct 19;13(10):e076155. doi: 10.1136/bmjopen-2023-076155
10. Sharma A, Prinja S, Rao KD, Aggarwal AK. Human Resources for Health inHaryana, India: What can be Done Better? WHO South East Asia J Public Health. 2023 Jan-Jun;12(1):4-14.doi: 10.4103/WHO-SEAJPH.WHO-SEAJPH_11_22.
11. Chauhan AS, Sharma D, Mehndiratta A, Gupta N, Garg B, KumarAP, Prinja S. Validating therigour of adaptive methods of economic evaluation. BMJ Glob Health. 2023 Sep;8(9):e012277. doi:10.1136/bmjgh-2023-012277.
12. Sharma D, Prinja S, Aggarwal AK, Rajsekar K,Bahuguna P. Development of the Indian ReferenceCase for undertaking economic evaluation for health technology assessment.Lancet Reg Health Southeast Asia. 2023 Jun17;16:100241. doi: 10.1016/j.lansea.2023.100241. eCollection 2023 Sep
13. Sarin KC, LinLW, Bayani DBS, Zemlyanska Y, Adler A, Ahn J, Chan K, Choiphel D,Genuino-Marfori AJ, Kearney B, Liu Y, Nakamura R, Pearce F, Prinja S, PwuRF, Shafie AA, Sui B, Suwantika A, Teerawattananon Y, Tunis S, Wu HM, ZalcbergJ, Zhao K, Isaranuwatchai W, Wee HL. What, Where, and How to Collect Real-World Data andGenerate Real-World Evidence to Support Drug Reimbursement Decision-Making inAsia: A reflection into the Past and A Way Forward. Int J HealthPolicy Manag. 2023;12:6858. doi: 10.34172/ijhpm.2023.6858. Epub 2023 Mar 6
14. Brar S, Kaur G, Muniyandi M, Karikalan N, Bano H, Bhansali A,Jain S, Kumari S, Prinja S. Cost of screening, out-of-pocketexpenditure & quality of life for diabetes & hypertension in India.Indian J Med Res. 2023 Jun;157(6):498-508. doi:10.4103/ijmr.IJMR_389_20.
15. Prinja S, Singh MP, Bahuguna P. India's publicly financed insurancescheme: scope for revision - authors' reply. Lancet Reg Health Southeast Asia. 2023 Jun 14;14:100236. doi:10.1016/j.lansea.2023.100236. eCollection 2023 Jul.
16. Jyani G, Yang Z, Sharma A, Goyal A, Stolk E, Purba FD, GroverS, Kaur M, Prinja S. Evaluation of EuroQol ValuationTechnology (EQ-VT) Designs to Generate National Value Sets: Learnings from theDevelopment of an EQ-5D Value Set for India Using an Extended Design (DEVINE)Study. Med Decis Making. 2023Aug;43(6):692-703. doi: 10.1177/0272989X231180134. Epub 2023 Jul 22
17. Rana K, Goel S, Prinja S. Effect of tobacco taxation onsmoking prevalence and smoking-attributable deaths in India. Indian J Public Health. 2023 Apr-Jun;67(2):278-283. doi:10.4103/ijph.ijph_93_22.
18. Hegde NC, Kumar A, Kaundal S, Saha L, Malhotra P, PrinjaS, Lad D, Patil AN. Generic ibrutiniba potential cost-effective strategy for the first-line treatment of chroniclymphocytic leukaemia. Ann Hematol. 2023Nov;102(11):3125-3132. doi: 10.1007/s00277-023-05342-y. Epub 2023 Jul 13.
19. Prinja S, Dixit J, Gupta N, Dhankhar A, Kataki AC, Roy PS, Mehra N,Kumar L, Singh A, Malhotra P, Goyal A, Rajsekar K, Krishnamurthy MN, Gupta S. Financial toxicity of cancertreatment in India: towards closing the cancer care gap. Front Public Health. 2023 Jun 19;11:1065737. doi:10.3389/fpubh.2023.1065737. eCollection 2023
20. Gupta N, Chugh Y, Chauhan AS, Pramesh CS, Prinja S. Cost-effectiveness ofPost-Mastectomy Radiotherapy (PMRT) for breast cancer in India: An economicmodelling study. Lancet Reg HealthSoutheast Asia. 2022 Aug 9;4:100043. doi: 10.1016/j.lansea.2022.100043.eCollection 2022 Sep.
21. Nehra P, Chauhan AS, Malhotra P, Kumar L, Singh A, Gupta N,Mehra N, Mathew A, Kataki AC, Gupta S, Prinja S. Cost-effectiveness analysis ofdifferent combination therapies for the treatment of chronic lymphocyticleukaemia in India. Lancet Reg HealthSoutheast Asia. 2023 May 2;13:100201. doi: 10.1016/j.lansea.2023.100201.eCollection 2023 Jun.
22. Prinja S, Singh MP, Aggarwal V, Rajsekar K, Gedam P, Goyal A,Bahuguna P. Impact of India's publicly financedhealth insurance scheme on public sector district hospitals: a health financingperspective. Lancet Reg HealthSoutheast Asia. 2022 Dec 17;9:100123. doi: 10.1016/j.lansea.2022.100123.eCollection 2023 Feb
23. Lahariya C, Sahoo KC, SundararamanT, Prinja S, Rajsekhar K, Pati S. Universalhealth coverage in India and health technology assessment: current status andthe way forward. Front PublicHealth. 2023 Jun 2;11:1187567. doi: 10.3389/fpubh.2023.1187567. eCollection2023.
24. Faujdar DS, Prinja S, Singh T,Sahay S, Kumar R. Costing analysis of an information &communications technology-enabled primary healthcare facility in India.Indian J Med Res. 2023 Apr;157(4):231-238.
25. Sirari T, Suthar R, Singh A, PrinjaS, Gupta V, Malviya M, Chauhan AS, Sankhyan N. Development and EconomicEvaluation of a Patient-Centered Care Model for Children With Duchenne MuscularDystrophy: Protocol for a Quasi-Experimental Study. JMIR Res Protoc. 2023 Apr 28;12:e42491.
26. Kumar D, Prinja S. Costingof services under National Tuberculosis Elimination Program at public healthfacilities of northern India. IndianJ Tuberc. 2023 Apr;70(2):232-238. doi: 10.1016/j.ijtb.2022.05.009. Epub 2022May 27.
27. Singh M, Sharma A, Bahuguna P, JyaniG, Prinja S. Cost-effectiveness analysis of 'test and treat' policyfor antiretroviral therapy among heterosexual HIV population in India.Indian J Med Res. 2022 Jun;156(6):705-714.doi: 10.4103/ijmr.IJMR_806_20.
28. Sinha A, Bahuguna P, Gupta SS, Kuruba YP,Poluru R, Mathur A, Raja D, Raut AV, Mahajan KS, Sudhakar R, Kulkarni B, PandeyRM, Arora NK, Prinja S. Studyprotocol for economic evaluation of probiotic intervention for prevention ofneonatal sepsis in 0-2-month old low-birth weight infants in India: theProSPoNS trial. BMJ Open. 2023Mar 29;13(3):e068215. doi: 10.1136/bmjopen-2022-068215
29. Prinja S,Sharma A, Nadipally S, Rana SK, Bahuguna P, Rao N, Chakraborty G, Shankar M,Rai V. Impactand cost-effectiveness evaluation of nutritional supplementation andcomplementary interventions for tuberculosis treatment outcomes under muktipay-for-performance model in Madhya Pradesh, India: A study protocol.Int J Mycobacteriol. 2023Jan-Mar;12(1):82-91. doi: 10.4103/2212-5531.307071
30. Jyani G, Prinja S,Garg B, Kaur M, Grover S, Sharma A, Goyal A. Health-related quality oflife among Indian population: The EQ-5D population norms for India. J GlobHealth 2023;13: 04018
31. Chugh Y, Jyani G, Trivedi M, Albert S, Kar SS, Patro B, RamanS, Rajsekar K, Baker RM, Donaldson C, Prinja S. Protocol for estimating thewillingness-to-pay-based value for a quality-adjusted life year to aid healthtechnology assessment in India: a cross-sectional study. BMJ Open. 2023 Feb 16;13(2):e065591. doi:10.1136/bmjopen-2022-065591.
32. Dixit J, Prinja S, Jyani G, Bahuguna P, Gupta A,Vijayvergiya R, Kumar R. Evaluatingefficiency and equity of prevention and control strategies for rheumatic feverand rheumatic heart disease in India: an extended cost-effectiveness analysis. Lancet Glob Health. 2023 Mar;11(3):e445-e455. doi:10.1016/S2214-109X(22)00552-6.
33. Gupta D, SinghA, Gupta N, Mehra N, Bahuguna P, Aggarwal V, Krishnamurthy MN, Roy PS, MalhotraP, Gupta S, Kumar L, Kataki A, Prinja S. Cost-Effectiveness of the First LineTreatment Options For Metastatic Renal Cell Carcinoma in India. JCO Glob Oncol.2023 Feb;9:e2200246. doi: 10.1200/GO.22.00246.
34. Chauhan AS, Prinja S, Selvaraj S, Gupta A,Muraleedharan VR, Sundararaman T. Cost of delivering Primary Health Carethrough Public Sector in India. Indian J MedRes. 2022 Sep;156(3):372-380. doi: 10.4103/ijmr.IJMR_67_19.
35. BaranwalAK, Prinja S, Kaur N. Congenital HeartDisease: Would It Be the Key Driver of Infant Survival During Amrit Kaal(2022-2047)? Indian Pediatr. 2023 Feb 15;60(1):98-102.
36. Chugh Y, Bahuguna P, Sohail A, Rajsekar K,Muraleedharan VR, Prinja S. Development of a Health Technology Assessment QualityAppraisal Checklist (HTA-QAC) for India.Appl Health Econ Health Policy. 2022 Oct 19:1-12. doi:10.1007/s40258-022-00766-5.
37. Gupta N, Pandey AK, Dimri K,Jyani G, Goyal A, Prinja S. Health-relatedquality of life among breast cancer patients in India. SupportCare Cancer. 2022 Oct 12. doi: 10.1007/s00520-022-07395-7
38. PurohitN, Prinja S. The Dynamics of Health, Productivity, andDevelopment: A Policy Prescription. Productivity. 2022; 62 (4).
39. Gupta N, Chugh Y, ChauhanAS, Pramesh CS, Prinja S. Cost-effectiveness of Post-MastectomyRadiotherapy
(PMRT) for breast cancer inIndia: An economic modelling study. The Lancet Regional Health - Southeast Asia
2022;00: 100043. Publishedonline https://doi.org/10.1016/j.lansea.2022.100043
40. Kumar D, Prinja S. Costingof services under National Tuberculosis Elimination Program at public healthfacilities of northern India. 2022. Forthcoming
41. Bahuguna P,Masaki E, Jeet G, Prinja S. Financing Comprehensive ImmunizationServices in Lao PDR: A fiscal space analysis from a public policyperspective. Appl Health Econ Health Policy. 2022 Sep 22:1-10. doi:10.1007/s40258-022-00763-8.
42. Gupta N, Gupta D, Dixit J,Mehra N, Singh A, Krishnamurthy MN, Jyani G, Rajsekhar K, Kalaiyarasi JP, RoyPS, Malik PS. Cost Effectiveness of Ribociclib and Palbociclib in theSecond-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic BreastCancer in Post-Menopausal Indian Women. Applied Health Economics and HealthPolicy. 2022 May 10:1-3.
43. Purohit N, Chugh Y, BahugunaP, Prinja S. COVID-19 Management: The Vaccination Drive in India. Health policyand technology. 2022 May 5:100636.
44. N Kaur, R Vijayvergiya, S Prinja, J Dixit,SK Sahoo, G Kasinadhuni. Economic Impact And SafetY of Same-Day DischargeFollowing Percutaneous Coronary Intervention: A Tertiary-Care Centre ExperienceFrom Northern India (EASY-SDD). Cardiovascular RevascularizationMedicine. 2022; 40: 71-77.
45. Singh, L. M., Siddhanta, A.,Singh, A. K., Prinja, S., Sharma, A., Sikka, H., & Goswami, L. (2022).Potential Impact of the Insurance on Catastrophic Health Expenditures Among theUrban Poor Population in India. Journal of Health Management. https://doi.org/10.1177/09720634221088425
46. Brar S, Purohit N, Singh G,Prinja S, Kaur M, Lakshmi PV. Health system readiness for roll out of theAyushman Bharat Health and Wellnes Centres-Early experiences from Punjab State.Journal of Family Medicine and Primary Care. 2022 Mar 18;11(4):1354-60.
47. Gupta N, Nehra P, ChauhanAS, Mehra N, Singh A, Krishnamurthy MN, Rajsekhar K, Kalaiyarasi JP, Roy PS,Malik PS, Mathew A. Cost Effectiveness of Bevacizumab Plus Chemotherapy for theTreatment of Advanced and Metastatic Cervical Cancer in IndiaA Model-BasedEconomic Analysis. JCO Global Oncology. 2022 Mar;8:e2100355.
48. Raithatha D, Sahu JK,Bhanudeep S, Saini L, Prinja S, Bharti B, Madaan P, Rana SK, Negi S.Financial Burden in Families of Children with West Syndrome. Indian Journal ofPediatrics. 2022; 89 (2): 118-24.
49. Jyani G, Sharma A, PrinjaS, Kar SS, Trivedi M, Patro BK, Goyal A, Purba FD, Finch AP, Rajsekar K,Raman S. Development of an EQ-5D Value Set for India Using an Extended Design(DEVINE) Study: The Indian 5-Level Version EQ-5D Value Set. Value Health. 2022 Jul;25(7):1218-1226. doi:10.1016/j.jval.2021.11.1370. Epub 2022 Jan 5.
50. Kaur A, Saini SK, Kaur G, PrinjaS. Quality of life of diabetes patients in North India: A comparison ofdifferent methodologies. International Journal of Noncommunicable Diseases.2022 Jan 1;7(1):22.
51. Chugh Y, Katoch S, Sharma D,Bahuguna P, Duseja A, Kaur M, Dhiman RK, Prinja S. Health-RelatedQuality of Life Among Liver Disorder Patients in Northern India. Indian JCommunity Med. 2022 Jan-Mar;47(1):76-81. doi: 10.4103/ijcm.ijcm_1033_21. Epub2022 Mar 16. PMID: 35368487; PMCID: PMC8971888.
52. Kaur G, Chauhan AS, PrinjaS, Teerawattananon Y, Muniyandi M, Rastogi A, Jyani G, Nagarajan K, LakshmiPV, Gupta A, Selvam JM. Cost-effectiveness of population-based screening fordiabetes and hypertension in India: an economic modelling study. The LancetPublic Health. 2022 Jan 1;7(1):e65-73.
53. Kumar D, Sharma A, Rana SK, Prinja S, Ramanujam K, Karthikeyan AS, Raju R, NjarekkattuvalappilSK, Premkumar PS, Chauhan AS,Mohan VR, Ebenezer SE, Thomas MS, Gupta M, Singh A, Jinka DR, Thankaraj S,Koshy RM, Dhas Sankhro C, Kapil A, Shastri J, Saigal K, Perumal SPB, Nagaraj S,Anandan S, Thomas M, Ray P, John J, Kang G. Cost of Illness Due to SevereEnteric Fever in India. J Infect Dis.2021 Nov 23;224(Supple 5):S540-S547. doi: 10.1093/infdis/jiab282
54. Prinja S, Gupta N. Value-based pricingfor cancer drugs in India. Cancer Research, Statistics, and Treatment. 2021 Jul1;4(3):559.
55. Gupta A, Sharda S, Jyani G,Prinja S, Goyal A, Gauba K. Modelling the impact of increase in sugar price ondental caries in India. Community Dent Oral Epidemiol. 2021;00:17. https://doi.org/10.1111/cdoe.12694
56. Gupta R, Singhal GL, Goyal A, Kaur G, Purohit N,Prinja S. Combatting the imbalance of sex ratio at birth: medium-term impact ofIndias National Programme of Beti Bachao Beti Padhao in the Haryana State ofIndia. Health Policy and Planning. 2021 Dec;36(10):1499-507.
57. Brar S, Purohit N, Prinja S,Singh G, Bahuguna P, Kaur M. What and how much do the community health officersand auxiliary nurse midwives do in health and wellness centres in a block inPunjab? A time-motion study. Indian J Public Health 2021;65:275-9
58. Gupta D, Jyani G,Ramachandran R, Bahuguna P, Ameel M, Dahiya BB, Kohli HS, Prinja S, Jha V.Peritoneal dialysisfirst initiative in India: a cost-effectiveness analysis. ClinicalKidney Journal, 2021, 18. doi: 10.1093/ckj/sfab126
59. KRana, S Goel, S Prinja. An analysis ofaffordability of cigarettes and bidis in India. Indian Journal ofTuberculosis 68, S55-S59
60. Dixit J, Brar S, Prinja S. Burdenof Group A Streptococcal Pharyngitis, Rheumatic Fever, and Rheumatic HeartDisease in India: A Systematic Review and Meta-Analysis. Indian J Pediatr. 2021 Aug 11.doi: 10.1007/s12098-021-03845-y. Online ahead of print.
61. Gupta N, JyaniG, Rajsekar K, Gupta R, Nagar A, Gedam P, Prinja S. Application of HealthTechnology Assessment for Oncology Care in India: Implications for AyushmanBharat Pradhan Mantri Jan Aarogya Yojana. Indian Journal ofMedical and Pediatric Oncology. 2021. Forthcoming
62. Prinja S, Dixit J, Gupta N, Mehra N, Singh A,Krishnamurthy MN, Gupta D, Rajsekar K, Kalaiyarasi JP, Roy PS, Malik PS, MathewA, Pandey A, Malhotra P, Gupta S, Kumar L, Kataki A, Singh G. Development ofNational Cancer Database for Cost and Quality of Life (CaDCQoL) in India: aprotocol. BMJ Open. 2021 Jul 29;11(7):e048513. doi:10.1136/bmjopen-2020-048513. PMID: 34326050; PMCID: PMC8323373.
63. Asrar MM, Lad DP, Bansal D, Prinja S, Khadwal A, PrakashG, Jain A, Jandial A, Malhotra P. Health-relatedquality of life in transplant eligible multiple myeloma patients with orwithout early ASCT in the real-world setting. Leuk Lymphoma. 2021 Jul 16:1-7. doi:10.1080/10428194.2021.1953011. Online ahead of print.
64. Morton A, Bish E, Megiddo I, Zhuang W, Aringhieri R, Brailsford S, DeoS, Geng Na, Higle J, Hutton D, Janssen M, Kaplan Ed, Li J, Oliveira M, Prinja S,Rauner M, Silal S, Song J. Introduction to the special issue: management sciencein the fight against Covid-19. Health Care Manag Sci. 2021Jun;24(2):251-252. doi: 10.1007/s10729-021-09569-x. Epub 2021 Jun 15.
65. Prinja S, Chugh Y,Rajsekhar K, Muraleedharan VR. National Methodological Guidelines to Conduct Budget Impact Analysisfor Health Technology Assessment in India. Appl Health Econ Health Policy. 2021 Jun 29:1-13. doi:10.1007/s40258-021-00668-y. Online ahead of print
66. Chauhan AS, Kapoor I, Rana S, Kumar D, Gupta M, JohnJ, Kang G, Prinja S. Cost Effectiveness of TyphoidVaccination in India. Vaccine. 2021. 2021Jun 10:S0264-410X(21)00713-1. doi: 10.1016/j.vaccine.2021.06.003.
67. Sharma D, Aggarwal AK, Wilkinson T, Isaranuwatchai W, Chauhan AS, Prinja S. Adherence to Country-Specific Guidelines AmongEconomic Evaluations Undertaken in Three High-Income and Middle-IncomeCountries: A Systematic Review. Int J Technol Assess Health Care. 2021 Jul 1;37(1):e73. doi:10.1017/S0266462321000404
68. Jeet G, Masaki E, Vassall A, Prinja S. Costingof Essential Health Service Packages: A Systematic Review of Methods fromDeveloping Economies. Value in Health. 2021. https://doi.org/10.1016/j.jval.2021.05.021
69. Chugh Y, De Francesco M, Prinja S. Systematic Literature Review of Guidelines on Budget Impact Analysis forHealth Technology Assessment. Appl Health Econ Health Policy. 2021 May 6. doi:10.1007/s40258-021-00652-6.
70. Chi YL, Blecher M, Chalkidou K, Culyer A, Claxton K, Edoka I,Glassman A, Kreif N, Jones I, Mirelman AJ, Nadjib M, Morton A, Norheim OF,Ochalek J, Prinja S, Ruiz F, Teerawattananon Y, Vassall A, Winch A.
What nextafter GDP-based cost-effectiveness thresholds? Gates Open Res. 2020 Nov30;4:176. doi: 10.12688/gatesopenres.13201.1. eCollection 2020.
71. Prinja S,Jyani G, Gupta N, Rajsekar K. Adapting health technology assessment for drugs,medical devices, and health programs: Methodological considerations from theIndian experience. Expert Rev Pharmacoecon Outcomes Res. 2021 May 3:1-9. doi:10.1080/14737167.2021.1921575. Online ahead of print.
72. Prinja S, Sharma A, Nimesh R, Sharma V, Madan Gopal K, BadgaiyanN, Lakshmi P, Gupta M.
Impact of National Health Mission on infant mortality in India: An interruptedtime series analysis. Int J Health Plann Manage. 2021 Jul;36(4):1143-1152. doi:10.1002/hpm.3166. Epub 2021 Mar 31.
73. Raithatha D, Sahu JK, Bhanudeep S, Saini L, Prinja S, Bharti B, Madaan P, Rana SK,Negi S. Financial burden in families of children withWest syndrome. Indian J Pediatr. 2021 May 26:1-7. doi:10.1007/s12098-021-03761-1. Online ahead of print
74. Rana K, Goel S, Prinja S. Perceivedeffect of increased pricing on smoked tobacco products quit rates: Across-sectional study in a block of Haryana. IndianJ Public Health. 2021 Jan-Mar;65(1):28-33. doi: 10.4103/ijph.IJPH_212_20.
75. Prinja S, Rajsekhar K, Gauba VK. Health Technology Assessment in India:Reflection and Future Roadmap. Indian J Med Res. 2020; 152(5): 444-447. doi: 10.4103/ijmr.IJMR_115_19
76. Singh D, Prinja S, Bahuguna P, Chauhan AS,Guinness L, Sharma S, Lakshmi P. Cost of scaling-up comprehensive primaryhealth care in India: Implications for universal health coverage. Health PolicyPlan. 2021; 36 (4): 407-17.
77. Kaur A, Jayashree M, Prinja S,Singh R, Baranwal AK. Cost analysis of pediatric intensive care: a low-middleincome country perspective. BMC Health Serv Res. 2021; 21(1): 168. doi:10.1186/s12913-021-06166-0
78. Chugh Y, Premkumar M, GroverGS, Dhiman RK, Teerawattanon Y, PrinjaS. Cost-effectiveness and budget impact analysis of facility-basedscreening and treatment of hepatitis C in Punjab state of India. BMJ Open.2021;11:e042280. doi:10.1136/bmjopen-2020-042280
79. Gupta N, Prinja S, Patil V, Bahuguna P. CostEffectiveness of Temozolamide for Treatment of Glioblastima Multiforme inIndia. JCOGlob Oncol. 2021; 7:108-117. doi: 10.1200/GO.20.00288.
80. PrinjaS, Singh MP, Rajsekar K, Sachin O, Gedam P, Nagar A, CHSI Study Group,Bhargava B. Translating Research to Policy: Setting Provider Payment Rates forStrategic Purchasing under India's National Publicly Financed Health InsuranceScheme. Applied Health Economics and Health Policy. 2021. 19(3):353-370. https://doi.org/10.1007/s40258-020-00631-3
81. Sharma D, Aggarwal AK,Downey L, Prinja S. NationalHealthcare Economic Evaluation Guidelines A Cross-country Comparison.Pharmacoeconomics Open. 2021. https://doi.org/10.1007/s41669-020-00250-7
82. Jyani G, Prinja S, Kar SS, Trivedi M, Patro B, Purba F, Pala S, Raman S,Sharma A, Jain S, Kaur M. Valuing health-related quality of life among theIndian population: a protocol for the Development of an EQ-5D Value set forIndia using an Extended design (DEVINE) Study. BMJ Open. 2020;10(11): e039517.
83. Jagnoor J, Ponnaiah M, Varghese M, Ivers R,Kumar R, Prinja S,Christou A, Jain T. Potentialfor establishing an injury surveillance system in India: a review of datasources and reporting systems. BMC PublicHealth. 2020 Dec 14;20(1):1909. doi: 10.1186/s12889-020-09992-9
84. Vassall A, Sweeney S, Barasa E, Prinja S, Keogh-Brown MR, Jensen HT,Smith R, Baltussen R, Eggo RM, Jit M. Integratingeconomic and health evidence to inform Covid-19 policy in low-and middle-incomecountries. Wellcome Open Research. 2020. 5(272): 272.
85. Lou J, Kc S, Toh KY, Dabak S, Adler A, Ahn J, Bayani DBS, Chan K,Choiphel D, Chua B, Genuino AJ, Guerrero AM, Kearney B, Lin LW, Liu Y, NakamuraR, Pearce F, Prinja S,Pwu RF, Shafie AA, Sui B, Suwantika A, Teerawattananon Y, Tunis S, Wu HM,Zalcberg J, Zhao K, Isaranuwatchai W, Wee HL. Real-world data forhealth technology assessment for reimbursement decisions in Asia: currentlandscape and a way forward. Int J Technol Assess Health Care. 2020 Sep 15;1-7. doi: 10.1017/S0266462320000628
86. Chauhan AS, Prinja S, Ghoshal S, Verma R.Cost-effectiveness of treating head and neck cancerusing intensity-modulated radiation therapy: implications for cancer controlprogram in India. Int J Technol Assess Health Care. 2020 Sep 23;1-8. doi: 10.1017/S0266462320000677
87. Chauhan AS, Prinja S, Srinivasan R, Rai B, MalligaJS, Gupta N, Ghoshal S. Cost Effectiveness of Strategies for Cervical CancerPrevention in India. PLoS One. 2020. 15(9): e0238291. https://doi.org/10.1371/journal.pone.0238291.
88. Sharma D, Aggarwal AK, Chauhan AS, Prinja S. Adherence of Health Economic Evaluations to CountrySpecific Guidelines: A Protocol for Systematic Review. InternationalJournal of Health Systems and Implementation Research. 2020; 4(2): 92-8.
89. Singh MP, Chauhan AS, Rai B, Ghoshal S, Prinja S. Cost of Treatment for Cervical Cancer in India.Asian Journal of Cancer Prevention and Research. 2020 Sep 1;21(9):2639-2646.doi: 10.31557/APJCP.2020.21.9.2639.
90. Jyani G, Chauhan AS, Rai B, Ghoshal S, Srinivasan R, PrinjaS. Health-related quality of life among cervical cancer patients in IndiaInt J Gynecol Cancer 2020;0:16. doi:10.1136/ijgc-2020-001455
91. Prinja S, Singh MP, Guinness L, Rajsekhar K, Bhargava B. Establishingreference costs for the health benefit packages under universal health coveragein India: cost of health services in India (CHSI) protocol. BMJ Open 2020;10:e035170.doi:10.1136/bmjopen-2019-035170
92. Sharma A, Singh AK, Singh LM, Rana SK, Mehboob S,Sharma V, Haldar K, Bhanot A, Muneeza KF, Srivastava A, Agarwal D, PrinjaS. Out-of-pocket Expenditure onHealthcare among the Urban Poor in India. Economic and PoliticalWeekly. 2020; 55 (32-33); 49-55.
93. Jeet G, Thakur JS, Prinja S, Singh M, Nangia R, SharmaD, Dhadwal P. Protocol for a systematic review of reviews evaluatingeffectiveness of mass media interventions for prevention and control ofnon-communicable diseases. BMJ Open. 2020;10(6):e032611. Published 2020Jun 3. doi:10.1136/bmjopen-2019-032611
94. Asrar MM, Lad DP, Prinja S, Bansal D. A systematicreview of economic evaluations of treatment regimens in multiple myeloma[published online ahead of print, 2020 Jun 4]. Expert Rev PharmacoeconOutcomes Res. 2020;10.1080/14737167.2020.1779064.doi:10.1080/14737167.2020.1779064
95. Prinja S, Pandav CS. Economics of COVID-19: challenges and the way forward forhealth policy during and after the pandemic. Indian J PublicHealth. 2020;64(Supplement):S231-S233. doi:10.4103/ijph.IJPH_524_20
96. Prinja S, Brar S, Singh MP, Rajsekhar K, Sachin O,Naik J, Singh M, Tomar H, CHSI Study Collaborating Investigators, Bahuguna P,Guinness L. Process Evaluation of Health System Costing Experience from CHSIStudy in India. PLoS One. 2020. 15(5):e0232873. doi: 10.1371/journal.pone.0232873. eCollection 2020.
97. Prinja S, Chauhan AS, Rajsekhar K,Downey L, Bahuguna P, Sachin O, Guinness L. Addressingthe Cost Data Gap for Universal Health Care Coverage in India: A National Health System Cost Database forIndia. Value in Health Regional Issues. 2020; 21: 226-29.
98. Downey LE, Dabak S, Eames J, Teerawattananon Y, De Francesco M, PrinjaS, Guinness L, Bhargava B, Rajsekar K, Asaria M, Rao NV, Selvaraju VK,Mehndiratta A, Culyer A, Chalkidou K, Cluzeau FA. Building Capacity for Evidence-Informed PrioritySetting in the Indian Health System: An International Collaborative Experience.Health Policy OPEN 1 (2020) 100004. http://dx.doi.org/10.1016/j.hpopen.2020.100004
99. Bahuguna P, Guinness L, Sharma S, Chauhan AS, Downey L, PrinjaS. Estimating the Unit Costs of Healthcare ServiceDelivery in India: Addressing Information Gaps for Price Setting and HealthTechnology Assessment. Appl Health Econ Health Policy.2020 Oct;18(5):699-711. doi: 10.1007/s40258-020-00566-9. [Epub ahead of print]
100. Gupta M, Lakshmi PVM, Prinja S, Singh T, Sirati T, Rao C,Kumar R. Comparative performance of verbal autopsy methods in identifyingcauses of adult mortality: A case study in India. Indian J Med Research. 2020. Forthcoming.
101. Gupta N, Verma RK, Gupta S, Prinja S. CostEffectiveness of Trastuzumab for Management of Breast Cancer in India. JCO GlobOncol. 2020 Feb;6:205-216. doi: 10.1200/JGO.19.00293.
102. Monga D, Verma R,Kumar D, Grover GS, Chauhan AS, Lakshmi PVM, Prinja S. Cost ofnational vector borne disease control programme In north India. Indian J Med Res. 2022 Jan;155(1):22-33. doi: 10.4103/ijmr.IJMR_2011_18.
103. Gupta N, Verma R, Dhiman RK, Rajsekhar K, PrinjaS. Cost effectiveness analysis and decision modelling: A tutorial forclinicians. Journalof Clinical and Experimental Hepatology. 2020; 10(2): 177184. Availableat https://jcehepatology.com/retrieve/pii/S0973688319302750
104. Singh LM, Prinja S, Rai P, Siddhanta A, SinghAK, Sharma A, Sharma V, Rana SK, Muneeza KF, Srivastava A. Determinants of Modern Contraceptive Use and UnmetNeed for Family Planning among the Urban Poor. Open Journal of SocialSciences. 2020; 8(5):451-73.
105. Gupta N, Pandey A, Dimri K, PrinjaS. Epidemiologicalprofile of retinoblastoma in North India: Implications for primary care andfamily physicians. J Family Med Prim Care.2020; 9: 2843-8.
106. Prinja S, Sharma A, Gupta I, Chowdhury S, Trivedi M. Health Research: A Counterargument. Economic and Political Weekly. 2019; 54 (49); 45-46.
107. Bahuguna P, Prinja S, Lahariya C, Dhiman RK,Kumar MP, Sharma V, Aggarwal AK, Bhaskar R, De Graeve H, Bekedam H. Cost-Effectivenessof Therapeutic Use of Safety-Engineered Syringes in Healthcare Facilities inIndia. Appl Health Econ Health Policy. 2019 Nov 19. doi:10.1007/s40258-019-00536-w. [Epub ahead of print]
108. Prinja S,Jagnoor J, Sharma D, Aggarwal S, Katoch S, Lakshmi PVM, Ivers R. Out-Of-PocketExpenditure and Financial Risk Protection for Hospitalization due to Injuriesin Public Sector Hospitals in North India. PLoS One. 2019. PLoS One. 2019 Nov7;14(11):e0224721. doi: 10.1371/journal.pone.0224721.
109. Prinja S, Muraleedharan VR, Sundararaman T. Cost Effectiveness Thresholdand Health Opportunity Cost: Building an Investment Case for Universal HealthCoverage in India. Economic and PoliticalWeekly. 2020. LV; 2: 19-23.
110. John O, Gummidi B, Tewari A, Muliyil JP, Ghosh A, SehgalM, Bassi A, Prinja S, Kumar V, Kalra OP, Kher V, Thakur JS, Ramakrishnan L, Pandey CM,Sivakumar V, Dhaliwal RS, Khanna T, Kumari A, Sharma J, Malakondiah P, Jha V. Studyto Test and Operationalize Preventive Approaches for CKD of UndeterminedEtiology in Andhra Pradesh, India. Kidney Int Rep. 2019 Jun 21;4(10):1412-1419. doi:10.1016/j.ekir.2019.06.003.
111. Gupta N, Verma R, Dhiman RK, Prinja S. Cost-effectivenessof Sorafenib for Treatment of Advanced Hepatocellular Carcinoma in India.Journal of Clinical and Experimental Hepatology. 2019; 9 (4): 468-75.
112. Chugh Y, Dhiman RK,Premkumar M, Prinja S, GroverGS, Bahuguna P. Real-world cost-effectiveness of pan-genotypicSofosbuvir-Velpatasvir combination versus genotype dependent directly actinganti-viral drugs for treatment of hepatitis C patients in the universalcoverage scheme of Punjab state in India. PLoS One. 2019; 14(8): e0221769.https://doi.org/10.1371/ journal.pone.0221769
113. Teerawattananon Y, Rattanavipapong W, Lin LW, Dabak SV,Gibbons B, Isaranuwatchai W, Toh KY, Cher BP, Pearce F, Bayani DB, Nakamura R,Pwu Raoh-Fang, Shafie AA, Adhikari D, Prinja S, Babidge W. Landscapeanalysis of Health Technology Assessment (HTA): Systems and practices in Asia.International Journal of Technology Assessment in Health Care. 2019;35(6):416-421.
114. Sharma D, Khaiwal R, KaurM, Prinja S, Mor S. Costevaluation of different household fuels and identification of barriers for thechoice of clean cooking fuels in India. Sustainable Cities and Society. 2020;52: Forthcoming.
115. Angell B, Dodd R, Palagyi A, Gadsden T,Abimbola S, Prinja S, Jan S,Peiris D. Primary health care financing interventions: asystematic review and stakeholder-driven research agenda for the Asia-Pacificregion. BMJ Glob Health. 2019 Aug 16;4(Suppl 8):e001481. doi:10.1136/bmjgh-2019-001481. eCollection 2019.
116. Prinja S,Chauhan AS, Bahuguna P, Selvaraj S, Muraleedharan VR, Sundararaman T. Cost of Delivering SecondaryHealthcare Through the Public Sector in India. Pharmacoecon Open. 2019 Aug 29. doi: 10.1007/s41669-019-00176-9.[Epub ahead of print]
117. Sharma A, Prinja S, Aggarwal AK. Comprehensivemeasurement of health system performance at district level in India: Generationof a composite index. Int J Health Plann Mgmt. 2019;117
118. Prinja S, Sharma A, Gupta I, Chowdhury S, Trivedi M. Designing a framework forbenefit packages: Achieving Universal Health Coverage in India. Economic andPolitical Weekly. 2019; LIV (30); 45-54.
119. Kaur G, Prinja S, Lakshmi PVM, Downey L, Sharma D, Teerawattananon Y.CriteriaUsed for Priority-Setting for Public Health Resource Allocation in Low- andMiddle-Income Countries: A Systematic Review. IntJ Technol Assess Health Care. 2019; 16:1-10.
120. Bahuguna P, Khaduja, Prinja S. EconomicAnalysis of Delivering Postpartum Intrauterine Contraceptive Device Services inIndia. Indian J CommunMed. 2019; 44 (2): 147-51
121. Jyani G, Prinja S, Ambekar A, Bahuguna P,Kumar R. Health impact and economic burden of alcohol consumption in India. Int J Drug Policy. 2019; 69: 34-42.
122. Jagnoor J, Prinja S, Nguyen H, Gabbe BJ, Peden M, Ivers RQ. Mortalityand health-related quality of life following injuries and associated factors: acohort study in Chandigarh, North India. InjPrev. 2019 Jul 4. pii: injuryprev-2019-043143. doi:10.1136/injuryprev-2019-043143.
123. Sharma A, Prinja S, Sharma A, Gupta A,Arora S. Cost of Anti-Retroviral Treatment for HIV Patientsin two treatment centres of North India. International Journal of STD& AIDS. 2019. 30(8):769-778.
124. Paika R, Thakur JS, Khurana D, Bhadada SK,Vijayvergiya R, Kapoor R, Prinja S.Developmentand cost estimates of an integrated noncommunicable disease registry in NorthIndia: A study protocol. International Journal of NoncommunicableDiseases. 2019; 4(2): 49.
125. Angell B, Prinja S, Gupt A, Jha V, Jan S.The Ayushman Bharat Pradhan Mantri Jan ArogyaYojana and the path to universalhealth coverage in India: overcoming the challenges of stewardship andgovernance. PLoS Med. 2019. 16(3): e1002759.https://doi.org/10.1371/journal.pmed.1002759.
126. Prinja S, Sharma YP, Dixit J, Thingnam SS, Kumar R. Cost of treatment ofvalvular heart disease at a tertiary hospital in North India: PolicyImplications. Pharmacoeconomics Open. 2019.https://doi.org/10.1007/s41669-019-0123-6.
127. Prinja S, Balasubramanian D, SharmaA, Gupta R, Rana SK, Kumar R. Geographic Inequities in Coverage of Maternal andChild health Services in Haryana State of India. Matern Child Health J.2019 Jan 30. doi: 10.1007/s10995-019-02733-4. [Epub ahead of print]
128. Kaur G, Prinja S, Lakshmi PVM, Downey L,Sharma D, Teerawattanon Y. Criteria for Priority Setting in Health Care: ASystematic Review of Evidence from Low and Middle- Income Countries. InternationalJournal of Technology Assessment in Health Care. 2019; 16:1-10.doi: 10.1017/S0266462319000473.
129. Bahuguna P, Mukhopadhyay I,Chauhan AS, Rana SK, Selvaraj S, PrinjaS. Sub-national health accounts: Experience from Punjab State in India.PLoS One. 2018 Dec 10;13(12):e0208298.
130. Maheshwari A,Sharma RR, Prinja S, Hans R, Modi M, Sharma N, Marwaha N. Cost-minimization analysis in the Indian subcontinent fortreating GuillainBarre Syndrome patients with therapeutic plasma exchange ascompared to intravenous immunoglobulin.J ClinApher. 2018 Oct 17. doi: 10.1002/jca.21646. [Epub ahead of print]
131. MacQuilkan K, Baker P, Downey L,Ruiz F, Chalkidou K,Prinja S, Zhao K, Wilkinson T, GlassmanA, HofmanK. Strengtheninghealth technology assessment systems in the global south: a comparativeanalysisof the HTA journeys of China, India and South Africa. Global HealthAction. 2018; 11(1): 1527556. DOI:10.1080/16549716.2018.1527556
132. Prinja S, Gupta A, Bahuguna P, Nimesh R. Cost analysis of implementing mHealth intervention for maternal, newborn & child health carethrough community health workers: assessment of ReMIND program in UttarPradesh, India.BMC Pregnancy Childbirth. 2018 Oct 3;18(1):390. doi: 10.1186/s12884-018-2019-3.
133. Gupta R, Nimesh R,SinghalGL, Bhalla P, Prinja S.Effectiveness of Indias National Program to Save the Girl Child: Experience ofBetiBachaoBetiPadao (B3P) Program from Haryana State. Health Policyand Planning. 2018; 33 (7): 870876, czy065, https://doi.org/10.1093/heapol/czy065
134. Sharma A, PrinjaS.Universal health coverage: Current status and future roadmapfor India.Int J Non-Communicable Dis. 2018;3(3): 78.
135. Prinja S, Bahuguna P, Gupta A, Nimesh R, Gupta M, Thakur JS. Cost effectivenessof mHealth intervention by community health workers for reducing maternal andnewborn mortality in rural Uttar Pradesh, India. Cost Effectiveness andResource Allocation. 2018; 16:25.
136. Monga D, Prinja S. Economics of SmokelessTobacco (SLT) in India. Indian Journal of Community Health. 2018. 30; (2).
137. Prinja S, Monga D, Rana SK, Sharma A,Dalpath S, Bahuguna P, Gupta R, Aggarwal AK. District level analysis of routine immunization inHaryana State: Implications for mission Indradhanush under universalimmunization programme. Indian JCommunity Med. 2018; 43(3): 215-20.
138. Jeet G, Thakur JS, Prinja S, Singh M, Paika R,Kunjan K, DhadwalP. Effectiveness of targeting the health promotion settingsfor non-communicable disease control in low/middle-income countries: systematicreview protocol. BMJOpen. 2018; 8 (6), e014559.
139. Gupta M, Kaur M,Lakshmi PVM, Prinja S, Singh T, Sirari T, Kumar R.Social autopsy for identifying causes of adult mortality. PLoSOne. 2018 May 31;13(5):e0198172. doi: 10.1371/journal.pone.0198172.
140. Prinja S,Kaur G,Gupta R, Rana SK, Aggarwal AK. Out of Pocket Expenditurefor Health Care: District Level Estimates for Haryana State in India. Int J Health Plann Manage. 2019Jan;34(1):277-293. doi: 10.1002/hpm.2628.
141. John JM, Jyani G, Jindal A, Mashon RS,Mathew A, Kakkar S, Bahuguna P, PrinjaS. Cost Effectiveness of Hematopoietic Stem CellTransplantation Compared to Transfusion Chelation for Treatment of ThalassemiaMajor. Biologyof Blood and Marrow Transplantation. 2018; DOI: https://doi.org/10.1016/j.bbmt.2018.04.005
142. Prinja S,BahugunaP, Faujdar DS, Jyani G, Srinivasan R, Ghoshal S, Suri V, Singh MP, Kumar R.Reply to"When Flawed Modeling Justify Cost-Effectiveness: Making sense ofBand-Aid modeling. 2018May 11. doi:10.1002/cncr.31544. [Epub ahead of print]
143. Kaur G, Prinja S, Ramachandran R,Malhotra M, Gupta KL, Jha V. Cost ofhemodialysis in a public sector tertiary
hospital of India. ClinicalKidney Journal. Clin Kidney J. 2018 Oct; 11(5): 726733.doi:10.1093/ckj/sfx152.
144. Prinja S,Bahuguna P, Faujdar DS, Jyani G, Srinivasan R, Ghoshal S, Suri V, Singh MP, Kumar R. Reply to The Reply to the letter on thecost-effectiveness of human papillomavirus in Punjab further distorts thescientific record. Cancer. 2018 Mar 1;124(5):1085-1086. doi: 10.1002/cncr.31226. Epub 2018Jan 11
145. Singh P, Lakshmi PVM, Prinja S, Khanduja P. Under-reportingof road traffic accidents in traffic police records-a cross sectional studyfrom North India. International Journal of CommunityMedicine and Public Health. 2018; 5(2): 579-584.
146. Downey LD, Rao N, Guinness L, Asaria M, Prinja S, Sinha A, Kant R,Pandey A, Cluzeau F, Chalkidou K. Identification of publicly available datasources to inform the conduct of Health Technology Assessment in India. F1000Research 2018, 7:245(doi: 10.12688/f1000research.14041.1)
147. Chauhan AS, Prinja S, Ghoshal S, Verma R, Oinam AS. Cost of treatment for head and neck cancer inIndia. PLoS One. 2018 Jan 11;13(1):e0191132. doi: 10.1371/journal.pone.0191132.eCollection 2018.
148. Sharma A, Prinja S, Aggarwal AK. Measurement of health system performance at district level: A studyprotocol.J Public Health Res. 2018Jan 2;6(3):917. doi: 10.4081/jphr.2017.917. eCollection 2017 Dec 13
149. Prinja S,Bahuguna, Faujdar DS, Jyani G, Srinivasan R, Ghoshal S, Suri V, Singh MP, Kumar R. Reply to Cost-effectiveness calculations ofhuman papillomavirus vaccination in Punjab may be flawed.Cancer. 2018 Jan1;124(1):214-216. doi: 10.1002/cncr.31074. Epub 2017 Oct 17.
150. Jagnoor J, PrinjaS, Christou A, Baker J,Gabbe B, Ivers R. Health related quality of lifeand function after paediatric injuriesin India: a longitudinal study. International Journal ofEnvironmental Research and Public Health. 2017; 14 (1144): 1-12.
151. Jeyashree K, PrinjaS, Kumar MI, Thakur JS. Inequity in access to inpatienthealthcare services for non-communicable diseases in India and the role ofout-of-pocket payments. Natl Med J India. 2017;30(5):249-254. doi:10.4103/0970-258X.234390.
152. Tripathy JP,Bahuguna P, Prinja S. Drug Prescription Behaviour: A crosssectional study in public health facilities in two states of North India. Perspectives in Clinical Research. 2017.DOI: 10.4103/picr.PICR_75_17.
153. Jeet G, ThakurJS, PrinjaS, Singh M. Community healthworkers for non-communicable diseases prevention and control in developingcountries: Evidence and implications.PLoS One. 2017 Jul 13;12(7):e0180640. doi:10.1371/journal.pone.0180640. eCollection 2017.
154. Prinja S,Gupta R, Sharma A, Dalpath S, Phogat A. Engaging Actors for Integrating HealthPolicy and Systems Research into Policy Making: Case Study from Haryana Statein India. Indian J Community Health.2017; 29(3):Available at: <http://www.iapsmupuk.org/journal/index.php/IJCH/article/view/1755>.
155. Prinja S,Bahuguna P, Duseja A, Kaur M, Chawla YK. Cost ofIntensive Care Treatment for Liver Disorders at Tertiary Care Level in India. Pharmacoeconomics Open. 2018.2: 179.DOI10.1007/s41669-017-0041-4.
156. Chowdhury S, Gupta I, PrinjaS, Trivedi M. Does Access to Basic Amenities Influence Health Status?Evidence from a Household Survey in Three States of India. Journal of Infrastructure Development. 2017; 9(1) 2335
157. Kaur G, Prinja S,Pankaj Malhotra, Lad DP, Prakash G, Khadwal A,Ramachandran R, Varma S. Cost of Treatment of Multiple Myeloma in a PublicSector Tertiary Care Hospital of North IndiaIndian J Hematol Blood Transfus.2017;DOI10.1007/s12288-017-0843-7
158. Prinja S,Downey LE, GaubaV, Swaminathan S. Health Technology Assessment for Policy Making inIndia:Current Scenario and Way Forward. PharmacoEconomics Open. 2018; 2(1): 1-3. DOI 10.1007/s41669-017-0037-0
159. Sarwa A, Aggarwal AK, Prinja S. Local Elected Leaders (Panchayat) can Play Key Rolefor Enrolment under National Health Protection Mission (NHPM) under AyushmanBharat: lessons learnt from Rashtriya Swasth Bima Yojna (RSBY) implementation.International Journal of Health Systems andImplementation Research. 2018; 2(1): 39-48.
160. Anindita, Ghai S, Sharma N, Prinja S. A Prospective Study To AssessThe Out of Pocket Expenditure Among Psychiatric Patients Attending TertiaryCare Service. International Journal of Scientific Research and Education. 2018;6(4): 7912-20.
161. Downey LE, Mehndiratta A, Grover A, GaubaV, Sheikh K, Prinja S, SinghR, Cluzeau FA, Dabak S, Teerawattananon Y, Kumar S, Swaminathan S.Institutionalising health technology assessment: establishing the MedicalTechnology Assessment Board in India. BMJ Glob Health. 2017;2:e000259. doi:10.1136/bmjgh-2016-000259
162. Prinja S, Nimesh R, GuptaA, Bahuguna P, Gupta M, Thakur JS. Impact of m-Health application used bycommunity health volunteers for improving utilization of maternal, newborn andchild health care (MNCH) services in a rural area of Uttar Pradesh, India. Tropical Medicine and International Health.2017. 22(7):895-907. doi:10.1111/tmi.12895.
163. Gupta M, Angeli F, Prinja S,Bosma H, Rana M, Kaur M, van Schayck OC.Utilizationof intergovernmental funds to implement maternal and child health plans of amulti-strategy community intervention in Haryana, North India: A retrospectiveassessment.Pharmacoeconomics Open. 2017. DOI 10.1007/s41669-017-0026-3.
164. Prinja S,Sharma S, Tripathy JP, Rana SK, Aggarwal AK, Dalpath SK. Inequalities innutritional status among under five children in Haryana state, India: Role ofsocial determinants. Indian J Comm Health. 2017; 29, 1: 81-88.
165. Prinja S, Bahuguna P, Faujdar DS,Jyani G, Srinivasan R, Ghoshal S, Suri V, SinghMP, Kumar R. Cost Effectiveness of HPVVaccination for Adolescent Girls in Punjab State: Implications for Indias UIPProgram. Cancer. 2017. 123(17):3253-3260.DOI: 10.1002/cncr.30734
166. Sangwan A, Prinja S,Aggarwal S, Jagnoor J, Bahuguna P, Ivers R. Cost of Trauma Care in Secondaryand Tertiary Care Public Sector Hospitals in North India. Applied HealthEconomics and Health Policy.2017;15(5):681-692. doi:10.1007/s40258-017-0329-7.
167. Jeet G, Prinja S,Aggarwal AK. Cost analysis ofa simulation based training for Health workforce in India. IndianJ Public Health. 2017. Apr-Jun;61(2):92-98. doi:10.4103/ijph.IJPH_189_15.
168. Chaudhary S, Gupta I, Trivedi M, Prinja S. Do health coverage schemes ensure financialprotection from hospitalization expenses? Evidence from eight districts inIndia. J Soc Econ Dev. 2017; DOI 10.1007/s40847-017-0040-4
169. Prinja S, Chauhan AS, Karan A, Kaur G, Kumar R. Impact of Publicly FinancedHealth Insurance Schemes on Healthcare Utilization and Financial RiskProtection in India: A Systematic Review. PLoSOne. 2017; 12(2): e0170996.doi:10.1371/journal.pone.0170996
170. Yanamandra U, Khattry N, Kumar S, Raje N, Jain A, Jagannath S, Menon H,Kumar L, Varma N, Varma S, Saikia T, Malhotra P, for IMAGE group. Consensus in the management of multiple myelomain India at Myeloma State of the Art Conference 2016. Indian J Hematol BloodTransfus. 2017; 2017. 33 (1): 15-21.
171. Prinja S, Kaur G, Malhotra P, Jyani G, Ramchandran R, Bahuguna P, Varma S.Cost- Effectiveness of Autologous Stem Cell Treatment as compared toConventional Chemotherapy for Treatment of Multiple Myeloma in India. IndianJ Hematol and Blood Transf. 2017. 33 (1): 33-40. DOI10.1007/s12288-017-0776-1
172. Gupta I, Chowdhury S, PrinjaS, Trivedi M. Out-of-Pocket Spending on Out-Patient Care in India:Assessment and Options Based on Results from a District Level Survey. PLoSONE. 2016; 11 (11): e0166775. doi:10.1371/journal. pone.0166775
173. Sharma D, Prinja S,Aggarwal AK, Bahuguna P, Sharma A, Rana SK. Out of Pocket Expenditure forHospitalization in Haryana State of India: Extent, Determinants and FinancialRisk Protection. Indian J Med Res. 2017; 146(6): 759-67.
174. Prinja S, Gupta A, Verma R, Bahuguna P, Kumar D, Kaur M, Kumar R. Cost ofDelivering Health Care Services in Public Sector Primary and Community HealthCentres in North India. PLoS One. 2016; 11(8): e0160986.doi:10.1371/journal.pone.0160986
175. Prinja S, Gupta R, Bahuguna P, Sharma A, Aggarwal AK, Phogat A, Kumar R. AComposite Indicator to Measure Universal Health Care Coverage in India: WayForward for Post-2015 Health System Performance Monitoring Framework. HealthPolicy Plannning. 2017, 32 (1): 43-56.
176. Prinja S, Jagnoor J, Chauhan AS,Aggarwal S, Nguyen H, Ivers R. Economic Burden of Hospitalization Due toInjuries in North India: A Cohort Study. Int. J. Environ. Res. Public Health.2016; 13: 673; doi:10.3390/ijerph13070673.
177. Prinja S, Nimesh R, Gupta A, Bahuguna P, Thakur JS, Gupta M, Singh T. Impactassessment and cost-effectiveness of m-health application used by communityhealth workers for maternal, newborn and child health care services in ruralUttar Pradesh, India: a study protocol. Glob Health Action. 2016, 9:31473.
178. Prinja S,Bahuguna P, BalasubramanianD, Sharma A, Kumar R. Analysing InequalityIn Use Of Healthcare Services: Implications For Targeting Within UniversalHealth Coverage Reforms. BMJ Global Health. 2016; 1 (Suppl 1): A24-A25.
179. Nandi A, Barter D, Prinja S,John TJ. Estimated Health and Economic Benefits of Three Decades of PolioElimination Efforts in India. Indian Pediar. 2016; 55 (Suppl 1): S7-S13.
180. Prinja S, Balasubramanian D, Jeet G, Verma R, Kumar D, BahugunaP, Kaur M, Kumar R. Cost of Delivering Secondary Level Health CareServices through Public Sector District Hospitals in India. Indian J Med Res. 2017Sep;146(3):354-361. doi: 10.4103/ijmr.IJMR_902_15.
181. Gupta M, Angeli F, Bosma H, Rana M, Prinja S, Kumar R, van Schayck OC. Effectiveness ofMultiple-Strategy Community Intervention in Reducing Geographical,Socioeconomic and Gender Based Inequalities in Maternal and Child HealthOutcomes in Haryana, India. PLoS One. 2016 22;11(3):e0150537. doi:10.1371/journal.pone.0150537. eCollection.
182. Sharma A, Rana SK, Prinja S,Kumar R. Quality of Health Management Information System for Maternal &Child Health Care in Haryana State, India. PLoS ONE. 2016 11(2):e0148449. doi:10.1371/journal.pone.0148449
183. Prinja S, Bahuguna P, Mohan P, Mazumdar S, Taneja K, Bhandari N, , van derHomberg, Kumar R. Cost Effectiveness of Integrated Management of Neonatal andChildhood Illnesses Program in India. PLoSOne. 2016. 11(1): e0145043. doi:10.1371/journal.pone.0145043.
184. Gupta M, Rao C, Lakshmi PVM, PrinjaS, Kumar R. Estimating mortality using data from civil registration: across-sectional study in India. Bull WHO. 2016. 94:1021 | doi:http://dx.doi.org/10.2471/BLT.15.153585
185. Thakur J, Prinja S,Jeet G, Bhatnagar N. Costing of a State-Wide Population Based Cancer Awarenessand Early Detection Campaign in a 2.67 Million Population of Punjab State inNorthern India. Asian Pac J Cancer Prev. 2016;17(2):791-7
186. Prinja S. Universal Health Coverage: A Step TowardsSustainableDevelopment. Yojana. 2016; June: 30-33.
187. Tripathy JP, Sharma A, PrinjaS. Is Mid-upper-arm-circumference alone sufficient to identify SevereAcute Malnutrition correctly? Indian Pediatrics. 2016. Indian Pediatr2016;53: 166-167.
188. Prinja S, Bahuguna P, Tripathy JP, Kumar R. Availability of medicines in publicsector health facilities of two North Indian States. BMC PharmacolToxicol.2015 Dec 23;16:43. doi: 10.1186/s40360-015-0043-8.
189. Prinja S, Bahuguna P, Gupta R, Sharma A, Rana SK,Kumar R. Coverage and Financial Risk Protection for Institutional Delivery: HowUniversal Is Provision of Maternal Health Care in India? PLoS ONE. 2015;10(9): e0137315. doi:10.1371/journal.pone.0137315
190. Prinja S, Chauhan AS, Angell B, Gupta I, Jan S. A Systematic Review of theState of Economic Evaluation for Health Care in India. Appl Health EconHealth Policy. 2015 Dec;13(6):595-613. doi: 10.1007/s40258-015-0201-6.
191. Thakur JS, Prinja S,Bhatnagar N, Rana SK, Sinha DN, Singh PK. Widespread Inequalities in tobacco consumptionacross wealth quintiles in states of India: need for targeted interventions. Indian J Med Res. 2015; 141: 789-798.
192. Kaur M, Prinja S, Kumar R.Evaluating the performance of health promotion interventions. Indian J Med Res. 2015Aug;142(2):109-12. doi: 10.4103/0971-5916.164213
193. Jagnoor J, Prinja S,Lakshmi PV, Aggarwal S, Gabbe B, Ivers RQ. The impact of road traffic injury inNorth India: a mixed-methods study protocol. BMJ Open. 2015 Aug19;5(8):e008884. doi: 10.1136/bmjopen-2015-008884.
194. Kumar R, Tripathy JP, Singh N,Kaur M, Prinja S, Lakshmi PVM, Gupta M, Madhanraj K, Bhattacharya S.Rapid Assessment of Health Services in Punjab using a Mixed Method Approach. Indian Journal of Community Health.2015: 27 (2): 197-203
195. Mock CN, Donkor P, Gawande A,Jamison DT, Kruk ME, Debas HT, for the DCP3 Essential Surgery Author Group.Essential surgery: key messages from Disease Control Priorities, 3rd edition. Lancet. 2015. Published online February5, 2015 http://dx.doi.org/10.1016/S0140-6736(15)60091-5.
196. Prinja S, Jagnoor J, Chauhan AS, Aggarwal S, Ivers R. Estimation of theeconomic burden of injury in north India: a prospective cohort study. TheLancet. 2015;385(S57).(Abstract).
197. Balasubramaniam D, PrinjaS, Aggarwal AK. Effect of User Charges on Secondary Level Surgical CareUtilization and Out-of-Pocket Expenditures in Haryana State, India. PLoS One. 2015. 10 (5): e0125202.doi:10.1371/journal.pone.0125202.
198. Thakur JS, Prinja S, Singh D,Rajwanshi A, Arora S, Prasad R, Parwana HK, Kumar R. Genotoxicity and adversehuman health outcomes among people living near highly polluted waste waterdrains of Punjab, India. World Journal of Pharmaceutical Research. 2015;4(1):895-08.
199. Prinja S, Kaur G, Kumar R. Roleof health economics in developing efficient universal health care system.Indian Journal of Community & Family Medicine. Jul-Dec 2015;1(02):28-33.
200. Prinja S, Bahuguna P, Lakshmi PVM, Mokashi T, Aggarwal AK, Kaur M, Reddy KR,Kumar R. Evaluation of Publicly Financed and Privately Delivered Model ofEmergency Referral Services for Maternal and Child Health Care in India. PLoS One. 2014. 9(10): e109911.doi:10.1371/journal.pone.0109911.
201. Megiddo I, Colson AR, Nandi A, Chatterjee S, Prinja S, Khera A, Laxminarayan R. Analysis of the UniversalImmunization Programme and Introduction of a Rotavirus Vaccine in India withIndiaSim. Vaccine. 2014; 32S: A151A161.
202. Kumar R, Gupta M, Prinja S.Illness burden, care seeking, and treatment cost among<2-year-old children in a rural area of Haryana. Indian J Pediatr. 2014 Dec;81(12):1347-52. doi:10.1007/s12098
203. Tripathy N, Saini SK, PrinjaS.Universal Access for Institutional Delivery:Impact of JananiShishuSurakshaKaryakramon Out-of-pocket Expenditure among Urban Slum Dwellers in North India. IndianPediatr. 2014; 15: 475-77.
204. Prinja S, Jeet G, Verma R, Kumar D, Bahuguna P, Kaur M, Kumar R. Economic Analysis of Delivering Primary HealthCare Services through Community Health Workers in 3 North Indian States.PLoS One. 2014. 13; 9(3): e91781. doi: 10.1371/journal.pone.0091781.
205. Prinja S, Bharaj G, Kaur M, Aggarwal AK, Manchanda N, Kumar R. Impact ofreferral transport system on health care utilization in Haryana, India.Indian J Med Research. 2014; 139:883-91.
206. Prinja S. Health and Development. Yojana.2014; Feb: 44-50.
207. Prinja S, Kathiresan J, Rana S, Sharma A, Kumar R. Wealth Related Inequalitiesin Self-Reported Morbidity: Positional Objectivity or EpidemiologicalTransition? Indian J Med Research.2014. Forthcoming.
208. Chakraborti A, Sekhar S, Singhi S, Kumar D, Prinja S, Gupta M, Kumar R Feasibility of Laboratory-BasedSurveillance for Childhood Pneumonia and Meningitis in District Hospitals Lab surveillance. J Commun Dis. 2013; 45(3&4) : 125-36.
209. Prinja S, Mazumder S, Taneja S, Bahuguna P, Bhandari P, Mohan P, Hombergh H,Kumar R. Cost of delivering child health care through community level healthworkers: How much does extra does IMNCI cost? Journal of Tropical Pediatrics. 2013. 59(6):489-95. doi:10.1093/tropej/fmt057
210. Prinja S, Manchanda N, Mohan P, Gupta G, Sethy G, Sen A, Hombergh HVD, Kumar R. Cost of Neonatal Intensive Care Deliveredthrough District Level Public Hospitals in India. Indian Pediatr. 2013; 50: 765-72.
211. Thakur JS, PrinjaS, Bhatnagar N, Rana SK, Sinha DN, Singh PK.Socioeconomic inequality in the prevalence of smoking and smokeless tobacco usein India. Asian Pac JCancer Prev. 2013; 14 (11):6965-9.
212. Prinja S, Manchanda N, Aggarwal AK, Kaur M, Bharaj G, Kumar R. Cost andEfficiency Evaluation of a Publicly Financed and Publicly Delivered ReferralTransport Service Model in Three Districts of Haryana State, India. Indian J Med Research. 2013.138(6):1003-11.
213. Prinja S, Kumar M, Pinto AD, Jan S, Kumar R. Equity in Hospital ServicesUtilization in India. Economic andPolitical Weekly. 2013; XLVIII (2): 52-58.
214. Singh A, Verma R, Chawla S, PrinjaS. Effects of indoor pollution among females in a rural block ofHaryana. Indian Journal of Health andWellbeing. 2013; 4(4): 895-7.
215. Singh A, Verma R, Khanna P,Chawla S, Prinja S. Knowledge, risk perception and compliance withuniversal precautions among health functionaries in a rural block of Haryana. Indian Journal of Health and Wellbeing.2013; 4(4): 885-7.
216. Prinja S, Aggarwal AK, Kumar R , Kanavos P. User Charges in Health Care:Effect on Service Utilization and Equity in Haryana. Indian J Med Research. 2012; 136: 868-72. Available at http://www.icmr.nic.in/ijmr/2012/november/1121.pdf.
217. Prinja S, Gursimerjeet, Kumar R. Validity of self-reported morbidity. Indian J Med Research. 2012; 136: 3-5.Available at http://www.icmr.nic.in/ijmr/2012/november/1101.pdf
218. Prinja S, Kaur M, Kumar R. Universal Health Insurance in India: Ensuringequity, efficiency and quality. Indian JCommun Med. 2012. 37 (3): 142-49.
219. Prinja S, Kanavos P, Kumar R. Health Care Inequities in North India: Role ofPublic Sector in Universalizing Health Care. Indian J Med Research. 2012; 136: 145-55.
220. Kaur M, Prinja S, Kumar P,Kumar R. Decentralizationof health services in India: barriers and facilitating factors. WHOSouth-East Asia Journal of Public Health 2012;1(1):94-104
221. Gupta M, Prinja S, Kaur M, KumarR. Cost effectiveness of Hib vaccine for introduction in national immunizationschedule in Haryana state, India. HealthPolicy and Planning. 2013Jan;28(1):51-61. doi: 10.1093/heapol/czs025. [Epub ahead of print].
222. Prinja S, Bahuguna P, Pinto AD, Sharma A, Bharaj G, Dhiman V, Tripathy JP,Kaur M, Kumar R. Cost of Universal Health Care Provision in India: aModel-Based Analysis. PLoS One. 2012.7(1): e30362.
223. Thakur JS,Prinja S, Mendis S, GargCG, Manabde N. Social and Economic Implications of Non-Communicable Diseases inIndia. Indian J Commun Med. 2011;Suppl (1): S13-S22.
224. Prinja S,Verma R. Estimating Catastrophic Health Expenditures: Need forImproved Methodology and Interpretation. IndianJ Commun Med. 2011; 36(3):239-40.
225. Kumar R, Mehendale SM, Panda S, Venkatesh S, Lakshmi P,Kaur M, Prinja S, Singh T, Virdi NK, Bahuguna P, Sharma AK, Singh S,Godbole SV, Risbud A, Manna B, Thirumagal V, Roy T, Sogarwal R, Pawar ND. Impact of Targeted Interventions on HeterosexualTransmission of HIV in India.BMCPublic Health. 2011; 11(1):549.
226. Prinja S, Bahuguna P, Rudra S, Gupta I, Kaur M, Mehendale S, Chatterjee S,Panda S, Kumar R. Cost effectiveness of targeted HIV prevention interventionsin India. Sex Transm Inf. 2011; 87:354-61.doi 10.1136/sti.2010.047829.
227. Verma R, Bairwa M, Chawla S,Prinja S, Rajput M. Should Chickenpox vaccine beincluded in the National immunization schedule in India?.Human Vaccines. 2011; 7(8):
228. Verma, R., Khanna, P., RajputM, Kalhan M, Prinja S. Why say no totobacco: Indian perspective. AustralasianMedical Journal. 2011; 4(3): 139-142.
229. Verma R, Khanna P, PrinjaS,Rajput M.Intra-dermal administration of rabies vaccines in developing countries: At anaffordable cost. Human Vaccines.2011; 7(7): 1-3.
230. ThakurJS, PrinjaS, Bhatia SPS. Persistent malnutrition in Chandigarh: Decadal underweight trends andimpact of ICDS Program. Indian Pediatrics.2011; 48: 315-18.Verma R, Khanna P, PrinjaS, Rajput M, Arora V. National Programme for Control of Blindness inIndia. AustralasianMedical Journal AMJ 2011, 4, 1, 1-3.
231. Gupta M, Prinja S, Kumar D, KumarR. Introducing pentavalent vaccine in India: Counsel for prudence ininterpretation of data. Indian J Med Res.2011. 133(5):560-2.
232. Lal S, Kumar R, PrinjaS, Singh GPI. Postgraduate teaching and evaluation in communitymedicine: challenges ahead. IndianJournal of Social and Preventive Medicine. 2011;42:221-225
233. VermaR, Khanna P, Prinja S,Meena, Arora V. The National Programme for Control of Blindnessin India. Australasian Medical JournalAMJ.2011,4,1,1-3
234. Verma R, Bishnoi A, Gaur DR,Aggarwal HK, Khanna P, Meena, Mohan, Prinja S.Prevalence and related factors of hypertension among adults in a rural area ofHaryana: A community-based study.AustralasianMedical Journal AMJ 2011, 4, 7,355-66
235. VermaR, Meena, Khanna P, Mohan, Mukesh, Prinja S.Prevalence of tobacco use & its correlate factors among school goingadolescents in rural areas of Haryana, India. Indian Journal of Public Health Research and Development. 2011, July- Dec:2 (2), 142-6
236. Verma R, Bairwa M, Chawla S, PrinjaS, Rajput M. New generation typhoid vaccines: An effective preventivestrategy to control typhoid fever in developing countries. HumanVaccines. 2011; 7: 8:1-3.
237. Verma R, Khanna P, Bairwa M,Chawla S, Prinja S, Rajput M. Adverse events following vaccination:Easily preventable in developing countries. Human Vaccines. 2011;7:9,1-3.
238. Verma R, Khanna P, Bairwa M,Chawla S, Prinja S, Rajput M. Introduction of a second dose of measles inNational immunization program in India: A major step towards eradication. HumanVaccines. 2011;7:10,1-3.
239. Verma R, Khanna P, Chawla S,Bairwa M, Prinja S, Rajput M. Hemophilusinfluenzaetypeb (Hib) vaccine: An effectivecontrol strategy in India. Human Vaccines.November 2011;7:11,1-3.
240. Verma R, Khanna P, PrinjaS, Rajput M, Chawla S, Bairwa M. HepatitisB vaccine in the national immunization schedule: A preventive step in India.Human Vaccines. December2011;7:12,1-2.
241. Verma R, Khanna P, PrinjaS, Rajput M. Crimean-Congohaemorrhagic fever: An outbreak in India.Australasian Medical Journal AMJ2011. 4,11 589-91.
242. ThakurJS, PrinjaS, Singh D, Rajwanshi A,Prasad R, Parwana HK, Kumar R. AdverseReproductive and child health outcomes among people living near highly toxicwaste water drains in Punjab, India. J Epidemiol Community Health 2010; 64:148-154. doi:10.1136/jech.2008.078568.
243. Prinja S,Gupta M, Singh AJ, Kumar R. Effectiveness of Decentralized Program Planning andManagement in Improving Age Appropriate Immunizations in a Rural Area of India.Bulletin WHO. 2010; 88: 97-103. doi: 10.2471/BLT.08.059543.
244. Prinja S,Kumar R. Reducing Health Inequalities in a Generation: A dream or Reality(Editorial). Bulletin WHO. 2009; 87:84. Prinja S, Thakur JS, Bhatia JS. Pilot testing of WHO child growthstandards in Chandigarh: Implications for Indias child health programs. Bulletin WHO. 2009; 87: 116-22.
245. Verma R., Khanna P., Prinja S., Rajput M., Arora, V.Public health security in 21st century: global issues. AMJ2010, 3, 13, 837-839. Doi: http//dx.doi.org/10.4066/AMJ.2010.472.
246. GuptaM, Kumar R, Deb AK, Bhattacharya SK, Bose A, John J, Balraj V, Ganguly NK, KantL, Kapoor AN, Watt J, Shearer J, Santosham M,on behalf of Hibstudyworking group. Multi-center surveillance for pneumonia & meningitis amongchildren (<2 yr) for Hib vaccine probe trial preparation in India.Indian J Med Res 131,May 2010, pp 649-658.
247. Prinja S,Gupta N, Verma R. Censoring in Clinical Trials: Review of Survival AnalysisTechniques. Indian J of Community Med.2010; 35 (2): 217-21.
248. Prinja S.Role of Ideas and Ideologies in Evidence-Based HealthPolicy. Iranian J Publ Health. 2010; 39(1): 64-69.
249. R. Verma, P. Khanna, Meena, S.Prinja. A Comparative Study between DOTS & Non-DOTS Patients in TwoDistricts of Haryana, India. The Internet Journal of Epidemiology. 2010Volume 8 Number 1.
250. Prinja S, Kumar S, Reddy GMM, Ratho RK, Kumar R. Outbreak investigation ofviral hepatitis E in a town in North India. J Commun Dis. 2008; 40(4): 249-54.
251. Kumar R, Prinja S, Lakshmi PVM. Health Care Seeking Behaviour of Adolescents:Comparative Study of Two Service Delivery Models. Indian J Pediatr. 2008 Sep; 75(9):895-9
252. Prinja S,Lal S, Verma R. Operationalization of Community NeedsAssessment Approach under Reproductive and Child Health Program at Subcentrelevel in North India. Regional Health Forum. 2007; 11(2): 39-44.
253. VermaR, Prinja S. Over reporting of RCH services coverage andoperational problems in Health Management Information System at Sub Centrelevel. Indian J Community Medicine. 2007; 32 (3): 185-88.
254. Prinja S, Lal S, Singh A, Verma R. Role of Panchayati RajInstitutions in decentralized village health planning in north India. SouthAsian Journal of Socio- Political Studies. 2007; 7(2): 23-6.
255. VermaR, Prinja S. Quality of records at Sub Centre level in a RuralBlock of District Rohtak. Indian J Community Medicine. 2007: 32(1): 90.
256. Ramesh Verma, ShankarPrinja: Evaluation of Health Management Information System for Maternaland Child Health Services at Subcentre Level in a Rural Block of Haryana, India.The Internet Journal of Third World Medicine. 2008. Volume 6 Number 2.
257. Shankar Prinja, Ramesh Verma, Sunder Lal: Role of ICDS program in delivery ofnutritional services and functional integration between anganwadi and healthworker in north India. The Internet Journal of Nutrition and Wellness. 2008.Volume 5 Number 2.
258. R. Verma, P. Khanna, D. Gaur,Meena & S. Prinja. Assessment of Nutritional Status and Dietary Intakeof Pre-School Children in an Urban Pocket. The Internet Journal of Nutritionand Wellness. 2008 Volume 6 Number 1.
259. Prinja S,Gupta N, Kaushal V, Verma R. National Cancer Control Programme. Radiation Oncology. 2006; 7(1): 12-15.
260. Prinja S,Verma R. Producing quality doctors: the dilemma of internship. IndianJournal of Community Medicine. 2006 Jan-Mar; 31(1):23. (letter).
261. Prinja S.Where health takes a back seat. Indian Journal of Community Medicine.2005, April-June; 5: 44. (letter)